Answers are grounded in this paper and cite their sources.
In their article describing successful riboflavin–ultraviolet A (UVA) corneal crosslinking to arrest and partially reverse the progression of laser in situ keratomileusis (LASIK)-induced iatrogenic keratectasia, Hafezi et al.1 have demonstrated that this technique is capable of increasing the biomechanical stability of these corneas. It would of course be of even greater benefit if the ectatic problem could be completely reversed. To accomplish this, I have performed the following procedure in a patient who developed ectasia after LASIK and another who had hyperopic automated lamellar keratomileusis. The preexisting corneal flap was elevated, then sutured snugly in place using continuous and interrupted 10-0 nylon sutures. A paracentesis was performed during the procedure to soften the globe and permit the flap to be appropriately flattened. Postoperatively, topical medications (travoprost [Travatan] and timolol and dorzolamide [Cosopt]) were used to maintain the intraocular pressure in the 10 to 15 mm Hg range. At the conclusion of each procedure, the keratectasia was completely eliminated and did not return as long as the continuous suture remained in place (interrupted sutures were selectively removed to eliminate astigmatism caused by their presence). Unfortunately, in both cases, the keratectasia rapidly returned after removal of the continuous suture approximately 1 year after surgery. (This was done because of suture erosion/exposure in both patients.) Based on this experience, I would recommend that the authors consider performing suture elimination of corneal ectasia prior to riboflavin–UVA crosslinking treatment. It is hoped that this sequential combination would restore the cornea to a pre-ectatic state that would persist after suture removal. Because riboflavin treatment for keratectasia is not a U.S. Food and Drug Administration–approved procedure, our European colleagues who are able to perform this treatment might be able to prove the above to be a successful means to eliminate this rare but serious complication of LASIK. With regard to eyes with keratoconus, thermokeratoplasty (TKP) as orginally described by Antonio Gossett could be used to flatten the cornea (it is virtually always successful in doing so, but unfortunately the effect is transient), followed immediately by riboflavin-UVA cross-linking treatment. Hopefully the latter would result in permanent flattening of the cornea.
No takes yet. Share an insight, caveat, or question.
Richard J. Mackool (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: